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Abstract Gelsolin is an actin filament severing protein com-
posed of six similar structured domains that differ with respect to
actin, calcium and polyphospho-inositide binding. Previous work
has established that gelsolin binds tropomyosin [Koepf, E.K. and
Burtnick, L.D. (1992) FEBS Lett. 309, 56^58]. We have
produced various specific gelsolin domains in Escherichia coli
in order to establish which of the six domains binds tropomyosin.
Gelsolin domains 1^3 (G1^3), G1^2 and G2 all bind tropomyosin
in a pH and calcium insensitive manner whereas binding of G4^6
to tropomyosin was barely detectable under the conditions tested.
We conclude that gelsolin binds tropomyosin via domain 2 (G2).
z 2000 Federation of European Biochemical Societies.
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1. Introduction
The actin cytoskeleton is principally responsible for the
structural integrity and motility of cells. The tendency of
monomeric actin (G-actin) to polymerise and the structure
of the resulting micro¢lament array is modulated by as
many as 60 distinct classes of actin binding proteins [1].
Gelsolin is a widely expressed actin binding protein [2^4]
that severs ¢laments and caps the barbed end of the ¢lament
[5]. The protein is composed of six repeating sequence seg-
ments [6] that encode six similar structural domains (G1^6)
consisting of about 120 amino acids each [7]. It is presumed
that the protein arose from a series of gene duplications, ¢rst
to produce a G1^3 containing protein (such as severin and
fragmin) [5] that was then itself duplicated to form G1^6. This
notion is supported by the observation that domains in the N-
terminus map best to the equivalent domain, in rank order, in
the C-terminus (G3^6), (G1WG4, G2WG5, G3WG6), in both
structure [6,7] and function [8].
Gelsolin requires calcium to sever ¢laments at neutral pH,
but there is no such requirement for calcium at pH 6.0 [9].
The calcium regulation of gelsolin seems to be brought about
by movements in G4^6 [10] since G1^3 alone severs ¢laments
without calcium. Gelsolin has two binding sites for G-actin, in
G1 and G4, and one ¢lamentous actin (F-actin) binding site
in G2. G1 binds G-actin tightly (Kd = 5 pM) in a calcium
insensitive manner while G4 has a moderate a⁄nity
(Kd = 1.8 WM) [8] actin binding activity that requires calcium.
The F-actin binding site in G2 has a lower a⁄nity (Kd = 5^7
WM) and binds to the same actin monomer as G1 within the
¢lament [11]. The regulation of gelsolin activity in vivo is less
certain [12].
Tropomyosins are found in almost all eukaryotic cells
where they bind laterally to micro¢laments [13]. They are
elongate, K-helical proteins that dimerise to form a parallel
K-helical coiled-coil interacting with other tropomyosin
dimers through their N- and C-termini. In muscle cells, tro-
pomyosins work together with troponins to form a calcium-
regulated switch for actomyosin contraction. Their function in
non-muscle cells is less clear but they appear to selectively
stabilise groups of micro¢laments and to modulate binding
of other actin binding proteins [14]. Many isoforms of tropo-
myosin are produced in vertebrate cells although little corre-
lation between the various isoforms and their cellular function
has yet been made [15].
In addition to actin and troponins, tropomyosin binds
many proteins including caldesmon [16], calponin [17,18],
S100 proteins [19,20], the LIM protein enigma [21], Rad
GTPase [22] and it has been reported to bind gelsolin
[23,24]. In this study, we con¢rm that tropomyosin binds gel-
solin, that this binding takes place mainly through G2 and
that the gelsolin:tropomyosin interaction has many similar-
ities to the interaction between actin micro¢laments and gel-
solin.
2. Materials and methods
2.1. Protein puri¢cation
Tropomyosin was prepared from rabbit back and leg muscle and
turkey breast muscle by the method of Bailey [25]. Recombinant hu-
man cytoplasmic gelsolin was produced in Escherichia coli carrying a
full length cDNA encoding gelsolin in the pMW172 plasmid as pre-
viously described [26] and puri¢ed by a modi¢cation of a previously
described method [27]. Brie£y, a 1 l culture was harvested by centri-
fugation and the cell pellet taken up in lysis bu¡er (50 mM Tris pH
8.0, 1 mM EGTA, 25% sucrose) and freeze-thawed with soni¢cation
three times. The supernatant was collected after a 10 min centrifuga-
tion at 13 000Ug, and dialysed against 10 mM Tris pH 8.0, 1 mM
NaN3, 1 mM EGTA, 1 mM benzamidine. A DE52 (Whatman) ion
exchange column was equilibrated with the same bu¡er and the pro-
tein added after clari¢cation (10 min at 13 000Ug). After a thorough
wash, gelsolin was eluted o¡ the column by replacing 2 mM CaCl2 for
the EGTA in the bu¡er. Gelsolin produced by this method was pure
as judged by SDS^PAGE. The gelsolin fragments G1, G2, G1^2, G1^
3, G4^6 were produced and puri¢ed as previously described [26,28,29].
Recombinant human non-muscle co¢lin was produced in BL21 (DE3)
transfected with a T7-based vector (pMW172) carrying the human
co¢lin cDNA fragment. Co¢lin was puri¢ed using the same method
previously used for human ADF [30], with an additional CM52
(Whatman) column step. Protein concentrations were determined
spectrophotometrically using the following extinction coe⁄cients
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(A280 = 1.0 cm31) and were: tropomyosin = 80 WM, gelsolin = 8.93 WM,
co¢lin = 74.0 WM, G1 = 49.7 WM, G1+10 = 49.7 WM, G2 = 79 WM, G1^
2 = 30.3 WM, G1^3 = 21.0 WM, G4^6 = 15.5 WM.
2.2. A⁄nity chromatography
Rabbit and turkey skeletal tropomyosin were linked to CNBr-acti-
vated Sepharose beads according to the manufacturer’s recommenda-
tions (Pharmacia) and subsequently washed three times with 0.1 M
Tris^HCl pH 7.5 to block any remaining active sites. 5 ml of tropo-
myosin-Sepharose beads was packed into ‘EconoColumns’ (Bio-Rad)
and equilibrated with various running bu¡ers (see the individual ¢gure
legends). 1 ml of test protein was added in the relevant bu¡er to
columns and 1 ml fractions collected under gravity feed. Protein elu-
tion was monitored by the optical density at 280 nm and, where
required, SDS^PAGE. Each column could be used repeatedly without
loss of binding capacity.
2.3. Light scattering measurements
Light scattering (90‡) was measured at 400 nm in a temperature-
controlled Perkin-Elmer LS-3B £uorescence spectrometer at 21‡C.
Bu¡ers and protein solutions (see the individual ¢gure legends for
details) were ¢ltered using 0.2 Wm ¢lters and de-gassed before each
experiment.
2.4. Sedimentation assays
Sedimentation of various fragments of gelsolin with tropomyosin
was performed in a Beckman bench top ultracentrifuge (TL-100).
15 WM turkey breast tropomyosin was incubated with 5 WM each of
the various gelsolin domains in 10 mM Tris pH 7.0, 2 mM CaCl2 for
1 h at room temperature. The centrifuge tubes were then sedimented
at 100 k for 15 min at 4‡C. The supernatants were removed and the
pellets taken up in sample bu¡er and analysed by SDS^PAGE.
3. Results
We have con¢rmed that tropomyosin binds directly to cy-
toplasmic gelsolin (Fig. 1). Experiments with whole gelsolin
were conducted with tropomyosins from turkey or rabbit
muscle but no di¡erence was seen (data not shown). Further-
more, we have discovered that the tropomyosin interaction
with gelsolin is both pH and calcium dependent. At pH 8.0,
calcium is required for maximal binding, whereas at pH 6.5,
calcium is not. A⁄nity chromatography (data not shown) and
turbimetric assays (Fig. 4) show that magnesium cannot be
substituted for calcium. G4^6 does not bind appreciably to
tropomyosin; conversely, G1^3 does bind. However, the pH/
calcium dependency seen with the whole gelsolin molecule is
not observed.
Results of several experiments such as those shown in Fig. 1
are presented in Table 1. Tropomyosin itself binds to the
tropomyosin a⁄nity column (but not Sepharose alone, data
not shown). Bovine serum albumin (BSA) did not bind tro-
pomyosin. Human recombinant ADF, human recombinant
co¢lin, actophorin (an ADF/co¢lin member from Acantha-
moeba) were also found not to bind the tropomyosin column
(data not shown). The smallest gelsolin fragment that binds
Fig. 1. Elution of human recombinant cytoplasmic gelsolin from a
turkey skeletal muscle tropomyosin a⁄nity column. (A) Excess gel-
solin (1 ml at 16.5 WM) was added to the column so that some
came straight through (£ow through fractions 4^20), the remaining
speci¢cally bound gelsolin was eluted o¡ the column with 0.5 M
KCl (fractions 25^30). Conditions: (b) 25 mM Tris pH 8.0, 1 mM
NaN3, 1 mM CaCl2. (E) 25 mM Tris pH 8.0, 1 mM NaN3, 1 mM
EGTA. (B) (b) 25 mM imidazole pH 6.5, 1 mM NaN3, 1 mM
CaCl2. (E) 25 mM imidazole pH 6.5, 1 mM NaN3, 1 mM EGTA.
Table 1
The binding of various proteins to skeletal muscle tropomyosin af-
¢nity columns
Protein EGTA Calcium
pH 6.5 pH 8.0 pH 6.5 pH 8.0
Gelsolin 0.43 0.29 0.50 0.81
G1 0.0 0.0 0.08 0.0
G1(+10) nd 0.03 0.0 nd
G2 0.41 0.39 0.48 nd
G1^2 nd 0.65 0.85 nd
G1^3 nd 1.18 1.06 nd
G4^6 nd 0.0 0.17 0.11
Tropomyosin nd 2.0 1.8 nd
Co¢lin 0.0 0.0 0.0 0.0
BSA 0.0 0.0 0.0 0.0
Data are expressed as the ratio of protein that £owed through the
column and the protein that was eluted o¡ the column by 0.5 M
KCl (i.e. integration of fractions 0^20 over fractions 25^30, in Fig.
1). (nd = not done).
Fig. 2. Tropomyosin at 2.5 WM in 10 mM Tris pH 6.8, 1 mM
CaCl2, 1 mM NaN3. Gelsolin or G4^6 added at time zero. Light
scattering measured at 400 nm.
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tropomyosin is G2 although the a⁄nity of the G2 domain
seems to be less than G1^2. Binding of G2 to tropomyosin
is not calcium sensitive.
Aggregation of tropomyosin caused by gelsolin and gelsolin
fragments was monitored by light scattering (Figs. 2 and 3).
Whole gelsolin caused a rapid increase in light scattering, but
only a very modest increase was observed in the presence of
large concentrations of G4^6 (Fig. 2). Although G2 did not
cause an increase in the light scattering of tropomyosin (Fig.
3), it inhibited the increase in light scattering produced by
G1^2. Note that G2 itself produced a small amount of light
scattering but that this amount was equivalent to the arith-
metic sum of that produced by tropomyosin and the G2 pro-
teins alone. Whereas the light scattering produced by G1^2
and tropomyosin was in huge excess of the arithmetic sum of
the two individual proteins. The inhibitory e¡ect of G2 on
light scattering by G1^2 was enhanced by pre-incubation of
G2 with tropomyosin (data not shown).
Mixing gelsolin, domains of gelsolin and tropomyosin
under certain conditions was found to cause rapid precipita-
tion. We used this observation to investigate the gelsolin:tro-
pomyosin interface by measuring the turbidity increase caused
by the gelsolin:tropomyosin precipitation (Table 2). The gel-
solin:tropomyosin precipitates were collected by co-sedimen-
tation and analysed by SDS^PAGE. Co-sedimentation experi-
ments (Fig. 5) were in good agreement with the turbidity data
(Table 2). Under the conditions used, tropomyosin itself pel-
leted to a limited extent, this was (if anything) slightly inhib-
ited by G2. G2 did not sediment either with tropomyosin or
alone (data not shown). In some experiments of this type,
there was no visible e¡ect of G2 on pelleting of tropomyosin
(data not shown). G1^2 was markedly di¡erent, causing a
signi¢cant amount of tropomyosin to pellet. This was strongly
inhibited by G2.
4. Discussion
Gelsolin is a well characterised, calcium and pH sensitive
Fig. 3. The e¡ect of G2 and G1^2 on the light scattering of tropo-
myosin. G2 inhibits the ability of G1^2 to increase the light scatter-
ing of tropomyosin solutions. 5 WM tropomyosin and 2.5 WM G1^2
added at 6 s (F). 5 WM tropomyosin with 2.5 WM G2 and 2.5 WM
G1^2 added at 6 s (a). 5 WM tropomyosin with 5 WM G2 and 2.5
WM G1^2 added at 6 s (b). 5 WM tropomyosin with 2.5 WM G2
added at 6 s (O). Conditions: 10 mM Tris pH 7.0, 2 mM CaCl2,
1 mM NaN3.
Fig. 4. Cation speci¢city of the gelsolin-induced aggregation of tro-
pomyosin. 2.5 WM tropomyosin was incubated with G1^3 in 10 mM
Tris pH 7.0, 1 mM NaN3 and MgCl2 added to 20 mM at 20 s. At
50 s, CaCl2 was added to a ¢nal concentration of 2 mM. Similar re-
sults were obtained with intact gelsolin (data not shown).
Table 2
Tropomyosin co-precipitation with gelsolin and various gelsolin do-
mains in the presence of calcium
Protein Precipitation
Gelsolin +++
G1^3 +++
G1^2 ++
G1^2 and G1^3 ++
G1 3
G2 3
G2 and G1^3 +
G2 and G1^2 +
G4^6 +/33 (weak)
Turkey breast tropomyosin (15 WM) was incubated with 5 WM each
of the various gelsolin domains in 10 mM Tris pH 7.0, 2 mM
CaCl2.
Fig. 5. Co-sedimentation of tropomyosin in the presence of G2 and/
or G1^2. Supernatant (S) and pellets (P) for each experiment are
shown. Conditions: 10 mM Tris pH 7.0, 1 mM CaCl2.
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actin binding protein [2,3,5]. Gelsolin binds both actin and
tropomyosin in the presence of calcium at pH 8.0, but both
interactions are calcium independent at pH 6.5. Calcium sen-
sitivity of both interactions at pH 8.0 is lost if G4^6 is re-
moved. It is known that gelsolin changes shape [31,32] upon
binding calcium. Recent data [7] suggest that this involves the
release of connections between the N- and C-termini. This
study has revealed that the manner in which gelsolin binds
tropomyosin is remarkably similar to the actin binding con-
ditions. We believe that it is likely that the tropomyosin bind-
ing site on G2 (and the actin binding sites) become exposed in
the presence of calcium when the G4^6 moves away and that
this movement can also occur at low pH. We have found
evidence for a weak interaction of tropomyosin for G4^6 in
addition to the stronger interaction with G2. It is possible that
whole gelsolin contains two tropomyosin binding sites, indeed
the work of Koepf and Burtnick [23] suggests that this is the
case. The second binding site may reside within G4^6 as the
gelsolin molecule has been duplicated (G1bG4, G2bG5 and
G3bG6) [6,7]. Although the second tropomyosin binding site
in G4^6 seems to be a low a⁄nity site, it is of course expected
that the net a⁄nity for whole gelsolin and tropomyosin would
be greater than the sum of the two individual sites.
The ¢nding that tropomyosin binds gelsolin, possibly in a
manner that would prevent gelsolin binding F-actin, allows us
to speculate that this may be a regulatory mechanism operat-
ing in the cell. Micro¢laments seem refractory to gelsolin-in-
duced disassembly in some cell types [33^35]. Also, gelsolin
does not produce overt actin rearrangement upon micro-in-
jection into ¢broblasts [12], despite the very e⁄cient actin
¢lament severing activity observed in vitro. This is probably
not as a result of inadequate cellular calcium, since calcium
was also micro-injected into these cell with gelsolin. When
G1^3 was introduced to the cell, however, the expected micro-
¢lament collapse was seen. There are of course a number of
possible explanations for this [12]. It is possible that the cal-
cium introduced to the cell was very rapidly removed, and
that this leads to inactivation of the gelsolin, whereas G1^3
being calcium insensitive remodelled the actin cytoskeleton to
produce the results observed [12]. Another possibility is that
tropomyosin switched the whole gelsolin o¡ as far as actin
binding is concerned, by binding to it, but that due to the
absence of the second site (within G4^6), the lower a⁄nity
of G1^3 for the inhibitory tropomyosin was low enough for
G1^3 to sever ¢laments. The discovery that tropomyosin af-
fords a degree of protection to actin ¢laments against severing
of gelsolin in vitro [36^38] is compatible with this view. It is
not likely that the inhibition of gelsolin is severing results
from competition of the two actin binding proteins for actin
since their a⁄nity for actin is so disparate.
Surprisingly, the structure of ADF/co¢lin [39] is similar to
G1 despite [40] having no recognisable sequence homology.
Like gelsolin, the severing activity of ADF/co¢lin is inhibited
by tropomyosin and this fact together with the structural sim-
ilarity encouraged us to investigate the binding of the co¢lins
to tropomyosin. However, we found no conditions under
which any of the ADF/co¢lin family members tested would
bind to the tropomyosin a⁄nity columns. The lack of ADF/
co¢lin binding together with the fact that gelsolin domains
other than G2 do not bind indicate that the interaction is
speci¢c and has little to do with the overall structural fold.
It is becoming clear that gelsolin may have a part to play in
a number of signal transduction pathways. Gelsolin binds and
regulates the activity of phospholipase D [41], phospholipase
C, either by phospholipid binding [42,43] or by a direct inter-
action [44], and gelsolin has been implicated in the process of
apoptosis [45]. A L-actin ‘zipcode’ binding protein has been
characterised [46] that is suggested to localise the L-actin
mRNA to the leading edge of ¢broblasts. Interestingly, gelso-
lin and tropomyosin both immuno-precipitated with the
L-actin mRNA binding protein, indicating that these three
proteins may form a trimeric complex. There is evidence
that in at least some cases, gelsolin is localised to the leading
edge of cells with tropomyosin, the later reportedly not com-
plexed with actin but with S100A2 proteins [20]. This inter-
action, like that between gelsolin and tropomyosin, is calcium
dependent. It remains to be seen if tropomyosin can bind
S100A2 simultaneously with gelsolin.
In addition to a possible role for gelsolin in signalling path-
ways, gelsolin [47], and tropomyosin [48], gene expression
alterations have been correlated with oncogenic change. It is
tempting to speculate that the interaction between tropomyo-
sin and gelsolin (through G2) may be involved in the regula-
tion of these signalling pathways.
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